U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06897969) titled 'Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment' on March 20.
Brief Summary: This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.
Study Start Date: April 01
Study ...